Abstrait
Le cancer du sein est le cancer le plus fréquent chez la femme dans les pays développés avec plus de 40 000 nouveaux cas par an en France et environ 10 000 morts chaque année. La très grande majorité des décès en rapport avec un cancer du sein est due à des métastases, en particulier osseuses, pulmonaires, hépatiques et cérébrales. Le processus métastatique est un processus complexe comprenant l’invasion de cellules tumorales à travers la membrane basale, leur passage dans le système vasculaire, la survie de ces cellules tumorales dans la circulation sanguine, la colonisation de la paroi vasculaire et l’extravasation des cellules tumorales dans les organes cibles et, enfin, la croissance tumorale au sein des organes cibles pour former une métastase (1).
Preview
Unable to display preview. Download preview PDF.
Références
Lu X, Kang Y (2007) Organotropism of breast cancer metastasis. J Mammary Gland Biol Neoplasia (in press)
Porter GJR, Evans AJ, Pinder SE et al. (2004) Patterns of metastatic breast carcinoma: influence of tumour histological grade. Clin Radiol 59: 1094–8
Perrotin F, Marret H, Bouquin R et al. (2001) Incidence, diagnostic et pronostic des métastases ovariennes du cancer du sein. Gynecol Obstet Fertil 29: 308–15
Hess KR, Varadhachary GR, Taylor SH et al. (2006) Metastatic patterns in adenocarcinoma. Cancer 106: 1624–33
Hamaoka T, Madewell JE, Podoloff DA et al. (2004) Bone imaging in metastatic breast cancer. J Clin Oncol 22: 2942–53
Sheafor DH, Frederick MG, Paulson EK et al. (1999) Comparison of unenhanced, hepatic arterial-dominant and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma. AJR 172: 961–8
Fennessy FM, Mortele KJ, Kluckert T et al. (2004) Hepatic capsular retraction in metastatic carcinoma of the breast occurring with increase or decrease in size of subjacent metastasis. AJR 182: 651–5
Nishino M, Hayakawa K, Nakamura Y et al. (2003) Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy. AJR 180: 129–34
Khalil HI, Patterson SA, Panicek DM (2005) Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Radiology 235: 872–8
Patterson SA, Khalil HI, Panicek DM (2006) MRI evaluation of small hepatic lesions in women with breast cancer. AJR 187: 307–12
Jung JI, Kim HH, Park SH et al. (2004) Thoracic manifestations of breast cancer and ist therapy. Radiographics 24: 1269–85
Casey JJ, Stempel BG, Scanlon EF et al. (1984) The solitary pulmonary nodule in the patient with breast cancer. Surgery 96: 801–5
Chinot O (2006) Métastases cérébrales. Rev Prat 56: 1799–804
Lin NU, Bellon JR, Winer EP (2004) CNS metastases in breast cancer. J Clin Oncol 22: 3608–17
Kreusel KM, Wiegel T, Stange M et al. (2000) Intraocular metastases of metastatic breast carcinoma in the woman. Incidence, risk factors and therapy. Ophthalmology 97: 342–6
Sant M (2001) Differences in stage and therapy for breast cancer across Europe. Int J Cancer 93: 894–901
Bruneton JN, Balu-Maestro C, Raffaeli C et al. (1996) Indications for hepatic ultrasonography in breast cancer staging and follow up. Breast cancer Res Treat 37: 121–65
Chen EA, Carlson GA, Coughlin BF et al. (2000) Routine chest roentgenography in unnecessary in the work-up of stage I et II breast cancer. J Clin Oncol 18: 3503–6
Ciatto S, Pacini P, Azzini V et al. (1988) Preoperative staging of primary breast cancer. A multicentric study. Cancer 61: 1038–40
Cox M, Gilliland R, Odling Smee GW et al. (1992) An evaluation of radionuclide scanning and liver ultrasonography for staging breast cancer. Austr NZ J Surg 32: 550–5
Gerber B, Seitz E, Müller H et al. (2003) Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread. Breast Cancer Res Treat 82: 29–37
Ravaioli A, Pasini G, Polselli A et al. (2002) Staging of breast cancer: new recommended standard procedure. Breast Cancer Res Treat 72: 53–60
Khatcheressian JL, Wolff AC, Smith TJ et al. (2006) American Society of clinical oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24: 5091–7
The GIVIO Investigators (1994) Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial. JAMA 271: 1587–92
Rosselli Del Turco M, Palli D, Cariddi et al. (1994) Intensive diagnostic follow-up after treatment of primary breast cancer: A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA 271: 1593–7
Rojas MP, Telaro E, Russo A et al. (2005) Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev CD001768
Whitlock JP, Evans AJ, Jackson L et al. (2001) Imaging of metastatic breast cancer: distribution and radiological assessment at presentation. Clin Oncol 13: 181–6
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag France
About this chapter
Cite this chapter
Taourel, P., Cyteval, C., Granier, C., Devaux, M., Suau, A. (2007). Imagerie de la maladie métastatique dans le cancer du sein. In: Cancer du sein avancé. Springer, Paris. https://doi.org/10.1007/978-2-287-72615-6_6
Download citation
DOI: https://doi.org/10.1007/978-2-287-72615-6_6
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-72614-9
Online ISBN: 978-2-287-72615-6